Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53 MDM2/X complex by potentially anticancer compounds

被引：4

作者：

Sgammato, Roberta ^{[1
,2
]}

Desiderio, Doriana ^{[3
]}

Lamberti, Anna ^{[1
]}

Raimo, Gennaro ^{[3
]}

Novellino, Ettore ^{[4
]}

Carotenuto, Alfonso ^{[4
]}

Masullo, Mariorosario ^{[1
,2
]}

机构：

[1] Univ Naples Parthenope, Dept Movement Sci & Wellness, I-80133 Naples, Italy

[2] CEINGE Biotecnol Avanzate Sc Arl, Naples, Italy

[3] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy

[4] Univ Naples Federico II, Dept Pharm, Naples, Italy

来源：

ELECTROPHORESIS | 2015年 / 36卷 / 24期

关键词：

Complex dissociation; Inhibitors; MDM2; MDMX; p53;

D O I：

10.1002/elps.201500305

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

A new analytical method to study the dissociation of the complexes between the oncosuppressor p53 and its negative modulators murine double-minute protein 2 (MDM2) or MDMX, is proposed. This technique is reliable to determine the dissociative power exerted by small molecules on the complex taking advantage of the appearance of migrating MDM2 or MDMX in a native polyacrylamide gel, when inhibitors are added to the complex mixture. Therefore, we propose this new approach to easily screen library of compounds, with potential pharmacological anticancer activity.

引用

页码：3101 / 3104

页数：4

共 50 条

[41] Dissociation Process of a MDM2/p53 Complex Investigated by Parallel Cascade Selection Molecular Dynamics and the Markov State Model
Duy Phuoc Tran
Kitao, Akio
JOURNAL OF PHYSICAL CHEMISTRY B, 2019, 123 (11) : 2469 - 2478
[42] Differential binding of p53 and nutlin to MDM2 and MDMX Computational studies
Joseph, Thomas Leonard
Madhumalar, Arumugam
Brown, Christopher John
Lane, David P.
Verma, Chandra
CELL CYCLE, 2010, 9 (06) : 1167 - 1181
[43] Expression of mdm2 and p53 in epithelial neoplasms of the colorectum
Hao, XP
Günther, T
Roessner, A
Price, AB
Talbot, IC
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (01): : 26 - 29
[44] p53 and MDM2 in the development and progression of bladder cancer
SchmitzDrager, BJ
Kushima, M
Goebell, P
Jax, TW
Gerharz, CD
Buttel, H
Schulz, WA
Ebert, T
Ackermann, R
EUROPEAN UROLOGY, 1997, 32 (04) : 487 - 493
[45] Alterations of the p53, Rb and MDM2 genes in osteosarcoma
Miller, CW
Aslo, A
Won, A
Tan, M
Lampkin, B
Koeffler, HP
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (09) : 559 - 565
[46] Targeting the p53–MDM2 interaction to treat cancer
C Klein
L T Vassilev
British Journal of Cancer, 2004, 91 : 1415 - 1419
[47] Small molecule inhibitors of p53/MDM2 interaction
Fotouhi, N
Graves, B
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 159 - 165
[48] Steady states and oscillations in the p53/Mdm2 network
Ciliberto, A
Novak, B
Tyson, JJ
CELL CYCLE, 2005, 4 (03) : 488 - 493
[49] Design of a novel MDM2 binding peptide based on the p53 family
Arumugam, Madhumalar
Jun, Lee Hui
Brown, Christopher J.
Lane, David
Verma, Chandra
CELL CYCLE, 2009, 8 (17) : 2828 - 2836
[50] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
Grinkevich, Vera V.
Vema, Aparna
Fawkner, Karin
Issaeva, Natalia
Andreotti, Virginia
Dickinson, Eleanor R.
Hedstrom, Elisabeth
Spinnler, Clemens
Inga, Alberto
Larsson, Lars-Gunnar
Karlen, Anders
Wilhelm, Margareta
Barran, Perdita E.
Okorokov, Andrei L.
Selivanova, Galina
Zawacka-Pankau, Joanna E.
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9

← 1 2 3 4 5 →